J&P (China) Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-29,750
Closed -$703K 14
2017
Q1
$703K Sell
29,750
-349,950
-92% -$6.93M 0.24% 6
2016
Q4
$5.14M Sell
379,700
-868,499
-70% -$14M 1.54% 6
2016
Q3
$23.2M Hold
1,248,199
6.33% 3
2016
Q2
$15.3M Hold
1,248,199
4.94% 4
2016
Q1
$8.41M Sell
1,248,199
-80,000
-6% -$512K 2.36% 5
2015
Q4
$12.3M Sell
1,328,199
-516,528
-28% -$4.8M 2.69% 6
2015
Q3
$33.2M Sell
1,844,727
-914,922
-33% -$21M 6.9% 4
2015
Q2
$82.1M Sell
2,759,649
-343,630
-11% -$8.63M 11.31% 3
2015
Q1
$68.3M Hold
3,103,279
9.64% 5
2014
Q4
$85.2M Buy
+3,103,279
New +$75.5M 8.62% 3

Other funds holding EXAS

J&P (China) Capital Management's EXAS Position: Q2 2017 in Review

J&P (China) Capital Management sold out of Exact Sciences (EXAS) in Q2 2017, closing a stake of 29,750 shares — an estimated $703K sold.

J&P (China) Capital Management first reported a position in EXAS in Q4 2014 and held it in 10 quarters. The position peaked at $85.2M in Q4 2014. 265 funds tracked by Wall St. Rank hold EXAS as of Q2 2017.

  • J&P (China) Capital Management reported no remaining Exact Sciences position as of Q2 2017 after selling out during the quarter.
  • J&P (China) Capital Management sold 29,750 Exact Sciences shares in Q2 2017, an estimated $703K.
  • J&P (China) Capital Management first reported a position in Exact Sciences in Q4 2014 and held it in 10 quarters.
  • J&P (China) Capital Management's Exact Sciences position peaked at $85.2M in Q4 2014.
  • 265 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2017.

Based on J&P (China) Capital Management's 13F filing for Q2 2017, filed 28 Jul 2017.